Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy

BACKGROUND: Adolescents with DMD treated with chronic high dose GC therapy typically have profound pubertal delay. Testosterone, the main circulating androgen in men, promotes virilisation and growth with associated accrual of fat-free muscle mass and bone mineral content. Testosterone therapy is ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wood, C. L., Cheetham, T. D, Hollingsworth, K. G, Guglieri, M., Ailins-Sahun, Y., Punniyakodi, S., Mayhew, A., Straub, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482579/
https://www.ncbi.nlm.nih.gov/pubmed/31023296
http://dx.doi.org/10.1186/s12887-019-1503-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482579/
https://www.ncbi.nlm.nih.gov/pubmed/31023296
http://dx.doi.org/10.1186/s12887-019-1503-x

Ejemplares similares